Klausner Mark R. 4
4 · Oxford Immunotec Global PLC · Filed Mar 2, 2018
Insider Transaction Report
Form 4
Klausner Mark R.
Director
Transactions
- Award
SHARE OPTION (RIGHT TO BUY)
2018-03-01+3,728→ 3,728 totalExercise: $10.93Exp: 2028-03-01→ ORDINARY SHARES (3,728 underlying) - Award
SHARE OPTION (RIGHT TO BUY)
2018-03-01+14,914→ 14,914 totalExercise: $10.93Exp: 2028-03-01→ ORDINARY SHARES (14,914 underlying)
Footnotes (2)
- [F1]This option will vest and become exercisable as to 100% of the underlying shares on the date of the first annual meeting of the issuer's shareholders held after the date of grant.
- [F2]This option will vest and become exercisable as to one-third of the shares on each date on which the first three annual meetings of the issuer's shareholders are held after the date of grant.